{"schema_version":"secwatch.filing_event.v1","accession":"0001477932-26-001167","form_type":"8-K","ticker":"TGNT","cik":"0000846377","company_name":"Totaligent, Inc.","filed_at":"2026-03-04T23:59:59+00:00","discovered_at":"2026-05-14T18:02:37.816370+00:00","generated_at":"2026-05-15T21:56:37.218742+00:00","sec_items":["1.01","9.01"],"event_type":"other_material","sentiment":"neutral","materiality_score":0.25,"calibrated_materiality_score":0.25,"confidence":"high","headline":"Totaligent extends target closing date for Aetherium Medical acqui-hire to March 20, 2026","bullets":["Extension Amendment moves target date for definitive agreements and closing from March 5 to March 20, 2026.","Exclusivity period under the LOI remains in effect through April 5, 2026.","Previously disclosed LOI on Feb 12, 2026, for acqui-hire of Aetherium team and IP in exchange for equity.","Only the target timeline changed; all other LOI terms unchanged."],"urls":{"canonical":"https://secwatch.observer/filing/0001477932-26-001167","json":"https://secwatch.observer/filing/0001477932-26-001167.json","markdown":"https://secwatch.observer/filing/0001477932-26-001167.md","text":"https://secwatch.observer/filing/0001477932-26-001167.txt","edgar_index":"https://www.sec.gov/Archives/edgar/data/846377/000147793226001167/0001477932-26-001167-index.htm","edgar_primary_document":"https://www.sec.gov/Archives/edgar/data/846377/000147793226001167/totaligent_8k.htm"},"model":{"generated_by":"deepseek-v4-flash:cloud@v2","generated_at":"2026-05-15T21:56:37.218742+00:00"},"review":{"review_status":"machine_generated","human_reviewed":false,"corrected":false,"correction_note":null,"correction_timestamp":null,"superseded_by":null,"related_filings":[]},"source_grounded_claims":[{"claim_id":"1016c90da030dc1aeaa70b24ebf92d266214adf6","claim":"Totaligent, Inc. amended Extension Amendment with Aetherium Medical (effective 2026-03-04).","evidence_excerpt":"On March 4, 2026, Totaligent, Inc. (the “Company”) entered into an Extension Amendment (the “Amendment”) to the Binding Letter of Intent dated February 11, 2026 (the “LOI”) with Aetherium Medical (“Aetherium”).","evidence_source":"SEC 8-K Item 1.01/1.02","evidence_url":"https://www.sec.gov/Archives/edgar/data/846377/000147793226001167/0001477932-26-001167-index.htm","confidence":0.9,"family_label":"Material Agreements","details":[{"label":"Action","value":"amendment"},{"label":"Counterparty","value":"Aetherium Medical"},{"label":"Effective","value":"2026-03-04"}]}],"license":"Source filings: public domain (SEC EDGAR). Summaries (headline + bullets): CC-BY-4.0; attribute https://secwatch.observer"}